CN106859585B - A kind of medical fibre Sigmoidoscope and preparation method thereof - Google Patents
A kind of medical fibre Sigmoidoscope and preparation method thereof Download PDFInfo
- Publication number
- CN106859585B CN106859585B CN201710088129.6A CN201710088129A CN106859585B CN 106859585 B CN106859585 B CN 106859585B CN 201710088129 A CN201710088129 A CN 201710088129A CN 106859585 B CN106859585 B CN 106859585B
- Authority
- CN
- China
- Prior art keywords
- fibro
- colonoscope
- antibacterial peptide
- preparation
- sigmoidoscope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to a kind of medical fibre Sigmoidoscopes and preparation method thereof.Being coated with one layer on the surface of the fibro-colonoscope has bactericidal effect antibacterial peptide layer, and the antibacterial peptide has the function of preferably killing pathogenic entero becteria.The fibro-colonoscope preparation is simple, low in cost, has preferable bactericidal effect, is suitable for promoting on a large scale, can effectively reduce patient for cross-infection risk, it is therefore prevented that the generation of malpractice.
Description
Technical field
The invention belongs to area of medical devices, specifically, are related to a kind of medical fibre Sigmoidoscope and preparation method thereof.
Background technique
Fibro-colonoscope is one kind of Sigmoidoscope.It is made of optical glass fibre and interior mirror body and attachment, it can be to total colectomy
It is line-of-sighted observation.Suitable for checking that colon is suspected to have the lesions such as polyp, tumour, ulcer, inflammation, unknown cause hemorrhagic focus.Match
X-ray clysis with barium or barium gas double contrast radiograph are closed, the diagnostic level of colonic pathological change can be improved.The major complications of inspection are enterobrosis.
Fibro-colonoscope is applicable in：Make rectum, caecum, colon ascendens, transverse colon, sigmoid colon, the inspections and examinations of colon and ileocecus etc.
Treatment, due to can directly visually see the lesion of each part mentioned above, so that diagnosis is correct, reliable.Endoscope takes with living body
Model machine structure.
Since in checking process, fibro-colonoscope enters rectum by anus, until large intestine, medical worker observe colon and
The inner case of large intestine, thus fibro-colonoscope inevitably contacts various bacteriums and the affected part in enteron aisle in diagnoses and treatment
Pathological tissues, pipeline is caused to infect, therefore it is necessary to targetedly thoroughly clean it after inspection, to guarantee
The clean and safe of each diagnoses and treatment avoids that cross-infection occurs.Current cleaning method is that fibro-colonoscope is put into cleaning
Cleaning and sterilizing in pond or washing and disinfecting machine, but mirror body internal corners still there may be the pathogens of remaining patient's body simultaneously
Thorough killing effect can not be played.
A kind of detergent of fibro-colonoscope is disclosed in 104498228 A of CN, by the raw material system of following weight
It is standby to form：78 parts of water, four 25-27 parts of benzenpropanoic acid pentaerythritol ester of (3,5- di-t-butyl -4- hydroxyls), 0,0- dimethyl-S- (first
Base carbamoyl methyl) 20-22 parts of phosphorodithioate, 26-28 parts of -2- acrylic acid of 3- (2,4_ 3,5-dimethylphenyl), 2,2- bis-
Methyl-1-16-18 parts of propyl alcohol, 2,2_ 12-15 parts of propyl alcohol diisooctyl succinate sodium sulfonate of dimethyl-1-, the tertiary fourth oxygen of (S)-N-
6-8 parts of benzene glycinol of carbonyl -2-, 8-10 parts of 4- acetylaminohydroxyphenylarsonic acid 2 hydroxybenzoic acid, 1- (4- fluorophenyl) -4- [4- (4- chlorobenzene
Base) the light base -1- piperidyl of -4-] 4-6 parts of -1- butanone.Although the detergent is removing stain and sterilization upper guarantee fiber colon on both side
The cleaning effect of mirror, but remain the bad defect of bactericidal effect.
Antibacterial peptide is a kind of small polypeptide to bacterium with very strong bactericidal effect, since the eighties in last century, antibacterial peptide
One of constituent as the biological innate immunity start behave find and recognize constantly have new antibacterial peptide each thereafter
The future drugs of anti-infective therapy are found and are considered as in kind biology.It, which has, carries positive charge, few drug resistance, fungicidal spectrum
Extensively, the features such as many kinds of, low to mammalian cell toxicity.The mechanism of action of antibacterial peptide is different from traditional antibiotic, disease
Opportunistic pathogen is not easy to generate it drug resistance, and some antibacterial peptides have very strong bactericidal activity to it, therefore is expected to kill using antibacterial peptide
The infection of bacterium especially pathogenic entero becteria.And the antibacterial peptide is used for the coating of the skin covering of the surface of fibro-colonoscope, it can be realized
The effect of the surface disinfection of fibro-colonoscope.
Summary of the invention
The purpose of the present invention is to defect of the existing technology, provide that a kind of structure is simple, and design rationally, prevents
The cross-infection of remaining pathogenic bacteria, prevents fibro-colonoscope from carrying the cross-infection of germ during fibercolonscopy.
One of the objects of the present invention is to provide the carrying sustained-release antimicrobial peptide paintings that a kind of strength is anti-infective and bacterium is inhibited to be formed
Layer medical fibre Sigmoidoscope.
The second object of the present invention is to provide a kind of manufacturing method of carrying sustained-release antimicrobial peptide coating medical fibre Sigmoidoscope.
The invention is realized in this way：A kind of carrying sustained-release antimicrobial peptide coating medical fibre Sigmoidoscope, including fibro-colonoscope
Ontology, it is characterised in that：The surfaces externally and internally of the fibro-colonoscope is coated with antibacterial peptide slow release layer, the antibacterial peptide slow release layer
To be combined with antibacterial peptide polymer coating.
Above-mentioned antibiotic slow release layer is with a thickness of 5-30 μm.
One of technical solution of the invention provides a kind of preparation method of fibro-colonoscope antibacterial surface coating of peptides, will
The ontology of fibro-colonoscope immerses the aqueous solution of polyethyleneimine, and the concentration of polyethyleneimine is 5-10mg/ml in the aqueous solution,
It is impregnated 40 minutes containing reciprocating vibration in 0.14mol/LNaCl, polymer base coat can be formed in the surfaces externally and internally of fibro-colonoscope；So
It is placed in the methanol solution for 4, the 4 '-Diphenyl disulfide alcohol that 100mL mass percent concentration is 0.01% and reacts 5 hours, instead
Fibro-colonoscope after answering is dried in vacuo after methanol sufficiently embathes, with antibacterial peptide respectively in horseradish peroxidase and peroxidating
The lower reaction of hydrogen effect, obtains the fibro-colonoscope of surface bond antibacterial polypeptide.When fibro-colonoscope and bacterial cell contact, pipe
The disulfide bonds in sublist face, reduction release polypeptide, play bactericidal effect.
The antibacterial peptide is to screen acquisition applicant's early period, and sequence is as follows：
KJT1：NTIWIPRRPHWQYWSQHWNTSPMTGLR
KJT2：QFFLQCGGGWVCSAHAWWMTRWWSQQR；
KJT3：WKHWGTIILNYEFRMNIAECFSGHDS；
KJT4：RLTWYPIYPMCHWCASAMYQYHHWLHQ；
KJT5：LSQVPGFIPMTHTRLQWLPVGPDQTRS；
KJT6：DRQHAATAQSLSLQYARFLVSWEQNNQ；
KJT7：RIEYHHNQYVTDVCSWQHKWDERGPWP；
The beneficial effects of the present invention are：The fibro-colonoscope with antibacterial peptide coating of this method preparation, having prevents
Fibro-colonoscope carries the germ of patient's body after use in vivo, and then causes other cross-patient contaminations that inflammation is caused to be sent out
Raw risk, with great application prospect and important social value value.Disinfection can be saved with the popularization of large area
Cost, and reduce medical-risk.
Specific embodiment
The preparation of 1 fibro-colonoscope coat of embodiment
Fibro-colonoscope is successively cleaned by ultrasonic 5 minutes, 10 points in distilled water, acetone, 70% ethyl alcohol, ultrapure water respectively
Clock, 10 minutes, after five minutes, then with ethane peroxide suffocating sterilization handle after, immerse the aqueous solution of polyethyleneimine, the aqueous solution
The concentration of middle polyethyleneimine is 10mg/ml, and reciprocating vibration impregnates 40 minutes in NaCl containing 0.14mol/L, can be in gastroscope pipe
Surfaces externally and internally formed polymer base coat；It is subsequently placed in 4, the 4 '-Diphenyl disulfides that 100mL mass percent concentration is 0.01%
It is reacted 5 hours in the methanol solution of alcohol, the pipe after reaction is dried in vacuo after methanol sufficiently embathes, and is existed with KJT-1 antibacterial peptide
Horseradish peroxidase and the lower reaction of hydrogen peroxide effect, obtain the fibro-colonoscope of surface bond antibacterial polypeptide, are named as
KJT-1 fibro-colonoscope.
According to the method described above, the fibro-colonoscope of KJT-2~7 is prepared respectively.
The compliance test result of 2 antibacterial peptide of embodiment
It is 2mg/ml that the polypeptide of KJT-1~7, which is dissolved into concentration with distilled water, carries out antibacterial activity using agar diffusion method
Detection.Bacterial strain used in agar diffusion method is Listeria monocytogenes, vibrio parahemolyticus, campylobacter jejuni, small
Yersinia enterocolitica, staphylococcus aureus, clostridium botulinum, C.perfringens, proteus, brucella, intestines
Enterohemorrhagic E.coli 0157:H7, Yersinia ruckeri and the combination of comma bacillus.After strain culturing, 50 microlitres of bacterium solutions are taken respectively
It is coated on LB solid medium.After standing band bacterium solution absorption, it is separately added into the polypeptide solution that concentration is 200ppm.37 DEG C of cultures 1
After hour, the presence or absence of observation inhibition zone and size.It the results are shown in Table 1.
1 polypeptide Analysis of Antimicrobial Activity result of table
7 polypeptides all have biggish inhibition zone.The effect for the inhibition pathogenic entero becteria having had in a short time
Fruit.
The hemolytic activity of 3 antibacterial peptide of embodiment
The new blood lmL of people or rabbit is acquired, is dissolved into PBS solution after anticoagulant heparin, I000g is centrifuged 5min, receives
Collect red blood cell；It is washed 3 times with PBS, then is resuspended with I0ml PBS；100 μ L red cell suspensions and 100 μ L PBS is taken to dissolve not
Antibacterial peptide solution with concentration is uniformly mixed, the constant-temperature incubation Ih in 37 DEG C of incubators；It is taken out after Ih, 4 DEG C of 1000g centrifugations
5min；It takes out supernatant microplate reader and surveys absorbance value at 540nm；Every group is averaged, and comparative analysis.Wherein 100 μ
1PBS is as negative control；100 μ 10.2%Tritonx-100 are as positive control.As a result, it has been found that 7 antibacterial peptides exist respectively
There is no the haemolysis imaginations under 2000 micrograms/ml concentration, have great application space.
The antibiotic property of fibro-colonoscope of the embodiment 4 containing polypeptides coating detects
7 kinds of fibro-colonoscopes that embodiment 1 is prepared and the not fibro-colonoscope of polypeptides coating, give respectively
With enterohemorrhagic escherichia coli 0157:The intestines problem patient of the H7 positive uses, and after use, passes through conventional cleaning and sterilization side
Formula is cleaned.Later, in sterile environment, fibro-colonoscope surfaces externally and internally is respectively placed in PBS water environment and shakes, rush
30min is washed, water body is then filtered by bacteriological filtration film, bacteriological filtration film surface is rinsed with culture medium, 37 degrees Celsius are cultivated for 24 hours, later
Detection is found, does not detect enterohemorrhagic escherichia coli 0157 in 7 kinds of gastroscopes being prepared using embodiment 1:H7 is thin
The presence of bacterium, without detecting enterohemorrhagic escherichia coli 0157 in the fibro-colonoscope of polypeptides coating:The presence of H7, it is total to cause
Germ bacterium number is 35 total.This also illustrates that polypeptides coating has preferable inhibition bacterium remaining in general fibre Sigmoidoscope
Function.
The coating of other several bacterium preparations uses other several pathogens：Yersinia ruckeri and comma bacillus carry out above-mentioned same
The inspection of sample does not detect the presence of pathogen in the fibro-colonoscope as the result is shown containing antibacterial peptide coating.
The above are specific embodiments of the present invention, its role is to be further described in detail to the contents of the present invention,
It is more readily understood reader, but is not constituted to protection of the presently claimed invention.
Sequence table
110 Nanchang > Qing Nang traditional Chinese medicine Co., Ltd of <
A kind of medical fibre Sigmoidoscope of 120 > of < and preparation method thereof
〈210〉1
〈211〉27
〈212〉PRT
〈400〉KJT1
NTIWIPRRPHWQYWSQHWNTSPMTGLR
〈210〉2
〈211〉27
〈212〉PRT
〈400〉KJT2
QFFLQCGGGWVCSAHAWWMTRWWSQQR；
〈210〉3
〈211〉26
〈212〉PRT
〈400〉KJT3
WKHWGTIILNYEFRMNIAECFSGHDS；
〈210〉4
〈211〉27
〈212〉PRT
〈400〉KJT4
RLTWYPIYPMCHWCASAMYQYHHWLHQ；
〈210〉5
〈211〉27
〈212〉PRT
〈400〉KJT5
LSQVPGFIPMTHTRLQWLPVGPDQTRS；
〈210〉6
〈211〉27
〈212〉PRT
〈400〉KJT6
DRQHAATAQSLSLQYARFLVSWEQNNQ；
〈210〉7
〈211〉27
〈212〉PRT
〈400〉KJT7
RIEYHHNQYVTDVCSWQHKWDERGPWP；
Claims (3)
1. a kind of medical fibre Sigmoidoscope, including fibro-colonoscope ontology, it is characterised in that：The interior appearance of the fibro-colonoscope
Face is coated with antibacterial peptide slow release layer, and the sequence of the antibacterial peptide in the antibacterial peptide slow release layer is SEQ ID NO：Any institute of 1-7
Show.
2. a kind of antibacterial peptide, it is characterised in that：Its sequence such as SEQ ID NO：Shown in 1-7 is any.
3. antibacterial peptide as claimed in claim 2 is in the application being used to prepare in medical fibre Sigmoidoscope as antibacterial peptide slow release layer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710088129.6A CN106859585B (en) | 2017-02-19 | 2017-02-19 | A kind of medical fibre Sigmoidoscope and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710088129.6A CN106859585B (en) | 2017-02-19 | 2017-02-19 | A kind of medical fibre Sigmoidoscope and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106859585A CN106859585A (en) | 2017-06-20 |
| CN106859585B true CN106859585B (en) | 2018-11-30 |
Family
ID=59166350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710088129.6A Expired - Fee Related CN106859585B (en) | 2017-02-19 | 2017-02-19 | A kind of medical fibre Sigmoidoscope and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106859585B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106037619A (en) * | 2016-07-08 | 2016-10-26 | 张学军 | Ear-nose-throat endoscope equipment |
| CN106236004A (en) * | 2016-06-20 | 2016-12-21 | 中国人民解放军军事医学科学院附属医院 | A kind of have the gastroscope preventing antibacterial residual function |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120035437A1 (en) * | 2006-04-12 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Navigation of a lumen traveling device toward a target |
-
2017
- 2017-02-19 CN CN201710088129.6A patent/CN106859585B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106236004A (en) * | 2016-06-20 | 2016-12-21 | 中国人民解放军军事医学科学院附属医院 | A kind of have the gastroscope preventing antibacterial residual function |
| CN106037619A (en) * | 2016-07-08 | 2016-10-26 | 张学军 | Ear-nose-throat endoscope equipment |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106859585A (en) | 2017-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Phillips et al. | Enterohaemorrhagic Escherichia coliO157: H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine | |
| Zhao et al. | Understanding bacterial biofilms: From definition to treatment strategies | |
| Ren et al. | Evaluation of detergents and contact time on biofilm removal from flexible endoscopes | |
| Thet et al. | SPaCE swab: point-of-care sensor for simple and rapid detection of acute wound infection | |
| Greco et al. | Staphylococcus epidermidis forms biofilms under simulated platelet storage conditions | |
| EP3423099B1 (en) | Use of bile acids and bile salts as anti bacterial agents for inhibition of bacterial conjugation and horizontal gene transfer | |
| Alipour et al. | Outbreak of hospital infection from biofilm-embedded pan drug-resistant Pseudomonas aeroginosa, due to a contaminated bronchoscope | |
| CN111484568A (en) | Chitosan-antibacterial polypeptide graft polymer and preparation method and application thereof | |
| Akers et al. | Biofilm formation by clinical isolates and its relevance to clinical infections | |
| CN101405013A (en) | Methods of treating or preventing peritonitis with oxidative reductive potential water solution | |
| Hou et al. | Gram-selective antibacterial peptide hydrogels | |
| Lee et al. | Basic amino acid-mediated cationic amphiphilic surfaces for antimicrobial pH monitoring sensor with wound healing effects | |
| CN105963680A (en) | Inhibitor used for inhibiting/disintegrating biofilm and application thereof | |
| CN110078794A (en) | A kind of antibacterial peptide and its application | |
| CN106859585B (en) | A kind of medical fibre Sigmoidoscope and preparation method thereof | |
| ES2387781T3 (en) | In vitro evaluation procedure for priocidal treatments (anti-prions) | |
| CN106236004B (en) | It is a kind of with the gastroscope for preventing bacterium residual function | |
| Zhang et al. | Quaternized carbon dots with enhanced antimicrobial ability towards Gram-negative bacteria for the treatment of acute peritonitis caused by E. coli | |
| Zühlsdorf et al. | Intralaboratory reproducibility of the German test method of prEN ISO 15883-1 for determination of the cleaning efficacy of washer–disinfectors for flexible endoscopes | |
| Gilling et al. | A randomised single‐blind comparison of the effectiveness of T ristel F use (chlorine dioxide) as an office‐based fluid soak, with C idex OPA (ortho‐phthaldehyde) using an automated endoscopic reprocessor (AER) as high‐level disinfection for flexible cystoscopes | |
| Ransjö et al. | A test for cleaning and disinfection processes in a washer‐disinfector Note | |
| Castro-Córdova et al. | Using a ligate intestinal loop mouse model to investigate Clostridioides difficile adherence to the intestinal mucosa in aged mice | |
| Parvin | Biofilms in healthcare: difficulty in removal | |
| RU2430373C1 (en) | Method of antibiotic therapy correction in patient of cardiosurgical profile | |
| Almjalawi et al. | Antibacterial activity of aqueous extract Cinnamomum zeylanicun against of Klebsiella pneumoniae isolated from Bacteremic patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Sheng Nan Inventor after: Lei Dongyun Inventor before: Lei Dongyun |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20181018 Address after: 272000 Department of Gastroenterology, Jining first people's Hospital, No. 6 health Road, Jining, Shandong Applicant after: Sheng Nan Address before: 330000, 8 floor, Guoli building, 889 Hongdu North Road, East Lake District, Nanchang, Jiangxi. Applicant before: Nanchang young capsule Chinese Medicine Co., Ltd. |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181130 Termination date: 20190219 |